Position in TAK
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$21,039,125
+$4,506,540 QoQ
Shares Held
1,136,022
+7.1% QoQ
Ownership
0.036%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 98.59650605357994.ToString("F0")%
Shared 0.ToString("F0")%
None 1.4034939464200518.ToString("F0")%
Common Shares in TAK Over Time
Shares Held
Position Value (USD)
Derivatives in TAK
reported options exposure · as of Mar 31, 2021CallValue
$675,620
CallShares
37,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026WELLS FARGO & COMPANY/MN holds $924,834,595 across 59 Drug Manufacturers - Specialty & Generic names. TAK ranks #5 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
5,491,173 | $649,111,558 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
77,138 | $45,741,289 | |
| 3 | HLN |
Haleon plc
|
4,022,749 | $40,267,716 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
231,311 | $30,472,908 | |
| 5 | TAK |
Takeda Pharmaceutical Co Ltd
This page
|
1,136,022 | $21,039,125 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
805,422 | $19,273,746 | |
| 7 | PBH |
Prestige Consumer Healthcare Inc.
|
300,133 | $17,788,881 | |
| 8 | VTRS |
Viatris Inc
|
1,160,097 | $15,672,908 |
All Filings in TAK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $21,039,125 | 1,136,022 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $16,532,585 | 1,060,461 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $15,141,595 | 1,034,262 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $15,661,318 | 1,013,022 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $14,391,586 | 967,827 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $11,435,096 | 863,678 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $13,907,187 | 978,002 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $11,279,370 | 871,667 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $11,819,624 | 850,945 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $11,052,855 | 774,552 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $11,784,981 | 761,796 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $11,924,675 | 759,050 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $14,740,683 | 894,459 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $14,511,463 | 930,222 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $11,453,675 | 883,090 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $12,273,753 | 874,199 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $11,738,575 | 819,733 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $24,214,210 | 1,776,538 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $36,446,399 | 2,225,055 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $38,181,494 | 2,268,657 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $46,001,886 | 2,519,271 | Shares | Defined | 2021-05-13 | |
| 2021-03-31 | $675,620 | 37,000 | Call | Defined | 2021-05-13 | |
| 2020-12-31 | $43,911,047 | 2,412,695 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $28,164,149 | 1,578,708 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $22,330,199 | 1,245,410 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $5,296,619 | 348,921 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||